by M. Aziz | Feb 16, 2017 | News
A recent letter in the NEJM by Janet M. Wojcicki, Ph.D., M.P.H. features the paragraph: Studies have shown cardiac risks associated with in utero exposure to zidovudine3 and poor growth outcomes at 5 years of age with exposure to nevirapine or zidovudine.4 However,...
